18 August, 2026 | Tuesday | News

-JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ‘Epaminurad (code name URC102)’ demonstrated excellent serum uric acid-lo...

26 August, 2026 | Wednesday | News

New Orbitrap Isora workflow integrates mass spectrometry, Vanquish Duo UHPLC System and Isotope Discoverer Software to bring molecular-level isotope ratio analysis to more researchers worldwide Key highlights:...

28 August, 2026 | Friday | News

Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operation...

20 August, 2026 | Thursday | News

Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since 2021, ena...

27 August, 2026 | Thursday | Analysis

On coming 4th September at six in the evening Singapore time, a public consultation will close. It opened on 7 August, it is still open as this is published, and it is not, on its face, about biological age tes...

28 August, 2026 | Friday | News

Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expanding access to AI-assisted colonoscopy across USA, EME...

24 August, 2026 | Monday | News

CureGene recently announced that the first subject has been dosed in its Phase I clinical trial of CG-0416, a novel oral liver-targeting THR-β agonist developed in-house, in Australia. Subject enrollment i...